Table 1.
Clinical characteristics of COVID-19 patients at ER.
| Demographic characteristics (n = 130) | |
|---|---|
| Sex, n (%) | |
| Male | 64 (49.2) |
| Female | 66 (50.8) |
| Age (years), n (%) | |
| Mean (SD) | 53.9 (16.4) |
| <34 | 16 (12.3) |
| 35–44 | 23 (17.7) |
| 45–54 | 30 (23.1) |
| 55–64 | 25 (19.2) |
| ≥65 | 36 (27.7) |
| COVID-19 characteristics | |
| Reported symptoms at ER, n (%) | |
| Headache | 97 (74.6) |
| Fever | 115 (88.5) |
| Malaise | 60 (46.2) |
| Myalgia | 39 (30.0) |
| Dizziness | 19 (14.6) |
| Cough | 105 (80.2) |
| Dyspnea | 81 (62.3) |
| Chest pain | 4 (3.0) |
| Expectoration | 19 (14.6) |
| Odynophagia | 12 (9.2) |
| Loss of smell/taste | 59 (45.4) |
| Diarrhea | 36 (27.7) |
| Radiological findings at ER, n (%) | |
| Pneumonia | 103 (79.2) |
| Bilateral pneumonia | 77 (59.2) |
| COVID-19 Confirmation (positive RT-PCR), n (%) | 89 (68.5) |
| Hospitalisation, n (%) | 104 (80.0) |
| Vital signs and inflammatory markers at the ER | |
| O2 requirements, n (%) | 31 (23.8) |
| Fever, n (%) | 45 (34.6) |
| Lymphopenia, n (%) | 70 (53.8) |
| CRP, mean ± SD, mg/ml | 9.3 ± 8.4 |
| IL-6, median (IQR), pg/ml | 34.0 (62.1) |
| D-dimer, median (IQR), ng/ml | 231.0 (243) |
| Ferritin, median (IQR), ng/ml | 354.0 (406) |
| LDH, mean ± SD, UI/L | 369.4 ± 221.4 |
ER: Emergency room; SD: standard deviation; IQR: interquartile range; ICU: intensive care unit; RT-PCR: real-time reverse transcriptase polymerase-chain reaction; O2: oxygen; lymphopenia (<1.0 × 109/L); CRP: C-reactive protein; IL-6: interleukin-6; LDH: lactate dehydrogenase.